Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-29

FDA Approved: HEPARIN SODIUM — Original Application (BE Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved BE Pharmaceuticals Inc.'s original application for Heparin Sodium (a generic anticoagulant). It is used to prevent and treat thrombosis, includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEPARIN SODIUM (HEPARIN SODIUM)

Snippet

ORIG AP for HEPARIN SODIUM (HEPARIN SODIUM)